The AMD Center
News
Emerging Treatments for Dry AMD
Demetrios Vavvas, MD, describes his recent talk on emerging treatments for dry age-related macular degeneration (AMD)…
Demetrios Vavvas, MD, PhD
Optimizing Visual Outcomes in Wet AMD
Carl Regillo, MD, talks about his recent presentation on how to optimize visual outcomes in patients with wet age-relate…
Carl D. Regillo, MD, FACS
ASSESS Study - 24 Months
Rishi P. Singh, MD, reviews details of the ASSESS study, which transitioned patients who had previously been treated wit…
Rishi P. Singh, MD
Drug Selection and Patient Outcomes in AMD
David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients…
David Eichenbaum, MD
Potential Treatments for AMD
Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in th…
Thomas Ciulla, MD
Displacement of Subfoveal Hemorrhage by Perfluorocarbon
Gurkan Erdogan, MD, presents an age-related macular disease (AMD) case with subretinal hemorrhage in a patient with sudd…
Gurkan Erdogan, MD
UK's Leading Blindness Organizations Meet to Address Macular…
The AMD Alliance International led an event at the House of Commons in January 2015 that addressed the current issues th…
Intraocular Miniature Telescope Lens
Howard Gimbel, MD, presents his technique for placing an intraocular miniature telescope for macular degeneration. This …
Howard Gimbel MD
Management of Myopic Choroidal Neovascularization
Professor Tien Yin Wong, MD, PhD shares his view on the management of Myopic Choroidal Neovascularization (myopic CNV), …
Professor Tien Yin Wong, MD, PhD
Management of Myopic Choroidal Neovascularization
Yasushi Ikuno, MD provides his perspective on the management of Myopic Choroidal Neovascularization (myopic CNV), includ…
Yasushi Ikuno, MD
Lower the Burden: Two-Year Efficacy of Stereotactic Radiothe…
Darius Moshfeghi, MD
Screening Patients and Treating with Oraya Therapy
Andre Luff, MA, FRCS, FRCS (Ophth), FRCOphth
Not What You Expect: Identifying and Assessing Microvascular…
Usha Chakravarthy, MD, FRCS, FRCOphth, PhD
Clinical Experience with Intravitreal Aflibercept for Wet AM…
As his amount of clinical experience with aflibercept increases, Arshad M. Khanani, MD, of Sierra Eye Associates, Reno, …
Arshad M. Khanani, MD
Genetic Polymorphisms Predict Response to Antioxidants and Z…
AREDS demonstrated that antioxidants and zinc supplements decreased progression of age-related macular degeneration (AMD…
Carl C. Awh, MD
Important Product Information
Jason S. Slakter, MD
Case 3: Female, 88
W. Lloyd Clark, MD, presents the case study of an 88-year old male with wet AMD that participated in the VIEW 1 trial of…
W. Lloyd Clark, MD
Case 2: Female, 72
W. Lloyd Clark, MD, presents the case study of a 72-year old female with wet AMD that participated in the VIEW 1 trial o…
W. Lloyd Clark, MD
Case 1: Male, 84
W. Lloyd Clark, MD, presents an 84-year old male with wet AMD that participated in the VIEW 1 trial of EYLEA® (afliberc…
W. Lloyd Clark, MD
wAMD Series Introduction
Jason S. Slakter, MD, presents the efficacy and safety findings of the VIEW 1 and VIEW 2 trials of EYLEA® (aflibercept)…
Jason S. Slakter, MD, W. Lloyd Clark, MD
Latest Observations on Wide-Field Imaging of Retinal Disease…
Szilárd Kiss, MD, an assistant professor of ophthalmology at Weill Cornell Medical College in New York, provides an upd…
Szilard Kiss, MD, Timothy G. Murray MD, MBA, FACS
Nothing in Vein: the Evolving Management of Retinal Venous O…
Julia A. Haller, MD, professor of ophthalmology at Jefferson University Hospitals in Philadelphia, discusses the evolvin…
Julia Haller MD, Timothy G. Murray MD, MBA, FACS
Anti-VEGF Maintenance Therapy for Neovascular AMD
Carl D. Regillo, MD, FACS, of Wills Eye in Philadelphia discusses using anti-VEGF for maintenance therapy in patients w…
Carl Regillo, MD, Timothy G. Murray MD, MBA, FACS
Systemic Levels of Anti-VEGF: What Available Data Reveal
Robert L. Avery, MD, discusses the recent finding from CATT, IVAN on systemic concentrations of bevacizumab and ranibizu…
Robert Avery MD, PhD
RPE Transplantation for Dry AMD
Carl Claes, MD
Case Presentation Wet AMD
Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD
Treatment Paradigm for Wet AMD: Australia, United Kingdom, a…
Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD
Intravitreal injection techniques: Australia, United Kingdom…
Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD
CNV for AMD
This video shows a case of CNV in AMD. A process of steps are taken where the retina is detached by injection. The retin…
Barbara Parolini, MD
ROP and Avastin
Carl Claes, MD
Twenty-five Gauge Vitretctomy for TRD and RRD Repair
The 25-gauge vitrector is utilized to repair this combined TRD and RRD. The retina is very thin, ischemic and mobile. Th…
Maria H. Berrocal, MD
A Clinical Understanding of Anti-VEGF Therapy in AMD
Richard F. Spaide, MD, provides an overview of neovascular age-related macular degeneration and the various therapies th…
Richard Spaide, MD
Two-Year Outcomes in the IVAN Trial
Usha Chakravarthy, MD, FRCS, FRCOphth, PhD, explains the results of a 24-month trial that investigated the differences b…
Usha Chakravarthy, MD, FRCS, FRCOphth, PhD
Results of the AREDS 2 Study
Srinivas R. Sadda, MD, shares the results of the AREDS 2 Study, which tested an updated formulation of the AREDS nutriti…
SriniVas Sadda, MD
Effects of Switching AMD Patients to Aflibercept
Ted Leng, MD, reviews the visual acuity and anatomic outcomes of eyes with age-related macular degeneration that were sw…
Ted Leng, MD
HARBOR 2 Results Support Individualized Dosing in Patients w…
Brandon Busbee, MD, discusses the HARBOR 2 study results, focusing on how the results support individualized dosing in p…
Brandon G. Busbee, MD
Implantation of Intraocular Mirror Telescope Implant as Ante…
Isaac Lipshitz, MD, evaluated the efficacy of a newly designed mirror telescopic implant (X2.5 Mag) for improving the vi…
Isaac Lipshitz, MD
Endpoint Management and PASCAL Laser Systems: Less-Damaging …
Pravin Dugel, MD, ophthalmologist at Retinal Consultants of Arizona, discusses the shift in the use of lasers for the tr…
Pravin U. Dugel MD
Wet AMD Case Presentation II
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Wet AMD Case Presentation III
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Wet AMD Case Presentation I
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Treatment Patterns for wet AMD
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Intravitreal Injections IV
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Intravitreal Injections III
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Intravitreal Injections II
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Intravitreal Injections I
Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD
Are multifocal IOLs contraindicated in AMD?
During the session on cataract surgery and macular disease held earlier today, Jean-François Korobelnik, MD, reviewed t…
Jean-François Korobelnik, MD
Foresee Preferential Hyperacuity Perimeter in Clinical Pract…
Paul Garfinkle, MD, discusses PHP (Preferential Hyperacuity Perimeter) in clinical practice as strategy for early detect…
Results of the LEVEL Study
The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age…
Thomas Friberg MD
Pharmacosurgery with the Intrector
Vitreo-Retinal pharmacosurgery with Intrector is the newest step for intravitreal combination therapy. In this video, Dr…
Frank Koch MD
InVitria: Intravitreal Injection Assistant
The InVitria (Medical Workshop, The Netherlands) is a disposable device for simplifying intravitreal injections and is d…
Arnaldo Gonçalves MD
Implantation of a Free Transplant of RPE and Choroid for Wet…
Bernd Kirchof, MD, presents a RPE transplantation in a retinotomy case and a complex case when a diamond blade cuts thro…
Bernd Kirchof MD
Significance of Mature Abnormal Vessels in the Treatment of …
Indication Visudyne® is indicated for the treatment of predominantly classic subfoveal choroidal neovascularization …
Mark S. Hughes MD
Challenges in the Management of AMD
Julia Haller, MD discusses the treatment of age-related macular degeneration (AMD).
Julia Haller MD
Implementing Intravitreal Injections in Clinical Practice
Nancy Holekamp, MD provides an overview of intravitreal injections in AMD management and shares her approach to incorpor…
Nancy Holekamp MD
SAILOR Cohort 1 Results
Dr. Boyer discusses the SAILOR cohort 1 results which evaluated safety, efficacy, and tolerability of intravitreal treat…
David Boyer MD
Vision-Related Function After Ranibizumab Treatment From ANC…
Dr. Bressler discusses the effects of ranibizumab treatments on visual acuity and patient's perception of improvemen…
Neil Bressler MD
Part I
AAO - 2007 Symposium: Implementing New Data to Treat the AMD Patient
LUCENTIS (Ranibizumab Injection) Overview
A comprehensive overview of LUCENTIS (Ranibizumab Injection)